Profile
Jeff Caravella is currently Chief Financial Officer at ABIOMED, Inc. since 2025.
Formerly, Mr. Caravella was Chief Financial Officer at BioTheryX, Inc. and Chief Financial Officer at Medicenna Therapeutics Corp.
in 2023.
Education includes undergraduate and MBAistration degrees from Syracuse University.
Jeff Caravella active positions
| Companies | Position | Start |
|---|---|---|
| ABIOMED, INC. | Director of Finance/CFO | 2024-12-31 |
Former positions of Jeff Caravella
| Companies | Position | End |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Director of Finance/CFO | 2023-10-25 |
BioTheryX, Inc.
BioTheryX, Inc. Packaged SoftwareTechnology Services Operates as a biopharmaceutical company that develops protein degradation platform | Director of Finance/CFO | - |
Training of Jeff Caravella
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
ABIOMED, Inc.
ABIOMED, Inc. Medical SpecialtiesHealth Technology Manufactures cardiac support, recovery and replacement devices | Health Technology |
BioTheryX, Inc.
BioTheryX, Inc. Packaged SoftwareTechnology Services Operates as a biopharmaceutical company that develops protein degradation platform | Technology Services |
Syracuse University
Syracuse University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medicenna Therapeutics Corp.
Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Jeff Caravella
















